If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

Director Dealing & Total Voting Rights

20 Apr 2015 07:00

RNS Number : 6313K
Ideagen PLC
20 April 2015
 

Ideagen plc

 

("Ideagen" or the "Company")

 

Exercise of Options, Director Dealing & Total Voting Rights 

 

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that it has applied for the admission to trading on AIM of a total of 1,918,080 new ordinary shares of 1p each ("Ordinary Shares") issued following an exercise (the "Exercise") of options over Ordinary Shares by directors (the "Directors") of the Company on 17 April 2015.

 

These new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares and admission is expected to be effective on 23 April 2015 (the "Admission").

 

Directors' Dealings

 

Following the Exercise, and on the same day, the Directors subsequently sold a total of 1,918,080 of these new Ordinary Shares, each at a price of 35 pence per Ordinary Share (the "Sale"), principally to fund the income tax and national insurance liabilities arising on the Exercise, as set out below.

 

Name of Director

New Ordinary Shares issued pursuant to the Exercise

Number of Ordinary Shares sold pursuant to the Sale

New holding of Ordinary Shares

New interest as a percentage of the Company's issued share capital

David Hornsby

2,800,000

1,780,800

9,404,033

5.30%

Graeme Spenceley

200,000

137,280

62,720

0.04%

Total

3,000,000

1,918,080

9,466,753

5.34%

 

 

Total Voting Rights

 

The Company advises that, following the issue of the new Ordinary Shares pursuant to the Exercise as set out above, the total number of Ordinary Shares in issue will be 177,341,678 and the total number of voting rights will therefore be 177,341,678. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules. 

 

 

 

Enquiries:

Ideagen Plc

Tel: 01629 699100

David Hornsby, Chief Executive

Graeme Spenceley, Finance Director

finnCap (Nominated Adviser and Broker)

Tel: 020 7220 0500

Stuart Andrews / James Thompson (Corporate Finance)

Stephen Norcross

(Corporate Broking)

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKLXFEKSEFF
Date   Source Headline
28th Apr 20223:19 pmBUSForm 8.3 - Ideagen PLC
28th Apr 202212:39 pmGNWForm 8 (DD) - [Ideagen PLC - 27 04 2022] - CGWL
28th Apr 202211:46 amRNSForm 8.5 (EPT/RI)
28th Apr 202211:02 amGNWForm 8.3 - Ideagen
28th Apr 20229:33 amRNSForm 8.3 - Ideagen Plc
28th Apr 20228:30 amRNSForm 8.5 (EPT/RI)
28th Apr 20227:00 amRNSForm 8.3 - Ideagen plc
27th Apr 20223:20 pmRNSForm 8.3 - Ideagen plc
27th Apr 20221:09 pmGNWForm 8.3 - Ideagen
27th Apr 202212:38 pmGNWForm 8.3 - [Ideagen Plc - 26 04 2022] - CGWL
27th Apr 202211:43 amRNSForm 8.5 (EPT/RI)
27th Apr 202211:40 amRNSForm 8.3 - Ideagen plc
27th Apr 202211:05 amRNSForm 8.3 - Ideagen plc
27th Apr 20227:00 amRNSForm 8.5 (EPT/RI) - Amendment
26th Apr 20223:20 pmRNSForm 8.3 - Ideagen plc
26th Apr 202212:37 pmGNWForm 8.3 - Ideagen
26th Apr 202212:26 pmGNWForm 8.3 - [Ideagen PLC - 25 04 2022] CGWL
26th Apr 202211:35 amRNSForm 8.5 (EPT/RI)
26th Apr 202211:34 amRNSForm 8.5 (EPT/RI)
26th Apr 202210:49 amRNSForm 8.3 - Ideagen plc
26th Apr 20227:00 amRNSForm 8 (OPD) Ideagen plc
25th Apr 20223:20 pmRNSForm 8.3 - Ideagen plc
25th Apr 20222:55 pmRNSForm 8.3 - Ideagen PLC
25th Apr 20221:15 pmGNWForm 8.3 - Ideagen PLC
25th Apr 202212:20 pmGNWForm 8.3 - [Ideagen plc - 22 04 2022] - (CGWL)
25th Apr 202211:45 amRNSForm 8.5 (EPT/RI)
25th Apr 202210:42 amGNWForm 8.3 - Ideagen
25th Apr 202210:10 amRNSForm 8.5 (EPT/RI)
25th Apr 20227:00 amBUSForm 8.3 - Ideagen PLC
22nd Apr 20223:20 pmGNWForm 8.3 - [IDEAGEN PLC - 21 04 2022] - CGWL
22nd Apr 20223:20 pmRNSForm 8.3 - Ideagen plc
22nd Apr 20223:10 pmBUSForm 8.3 - Ideagen PLC
22nd Apr 20221:56 pmGNWForm 8.3 - Ideagen PLC
22nd Apr 202211:23 amRNSForm 8.3 - Ideagen PLC
22nd Apr 202211:09 amGNWForm 8.3 - Ideagen
22nd Apr 202211:08 amRNSForm 8.5 (EPT/RI)
22nd Apr 20228:52 amRNSForm 8.5 (EPT/RI)
22nd Apr 20227:57 amRNSForm 8.3 - Ideagen PLC
21st Apr 20223:20 pmRNSForm 8.3 - Ideagen plc
21st Apr 202212:19 pmGNWForm 8.3 - [Ideagen PLC - 20 04 2022] - (HHL)
21st Apr 202211:30 amRNSForm 8.5 (EPT/RI)
21st Apr 202211:06 amRNSForm 8.3 - Ideagen PLC
21st Apr 202210:21 amRNSForm 8.3 - Ideagen plc
20th Apr 20224:26 pmRNSForm 8.3 - Ideagen plc
20th Apr 20223:50 pmEQSForm 8.3 - Maitland Institutional Services Limited: Ideagen Plc
20th Apr 20223:28 pmRNSForm 8.3 - Ideagen Plc
20th Apr 20223:20 pmRNSForm 8.3 - Ideagen plc
20th Apr 20223:18 pmRNSForm 8.3 - Ideagen Plc
20th Apr 20223:13 pmBUSForm 8.3 - Ideagen PLC
20th Apr 20221:28 pmGNWForm 8.3 - Ideagen PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.